Injectable Hormones and Regulatory Controversy: An End to the Long-Running Story?

• 1 January 1993
• journal article
• Published by JSTOR in Family Planning Perspectives
• Vol. 25  (1) , 37-40
• https://doi.org/10.2307/2135992

Abstract

Keywords

• BIOLOGY
• BIRTH WEIGHT
• BODY WEIGHT
• BREAST CANCER
• CANCER
• CERVICAL CANCER
• CONTRACEPTION
• CONTRACEPTION RESEARCH
• CONTRACEPTIVE AGENTS, FEMALE--COST
• CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS
• CONTRACEPTIVE AGENTS, PROGESTIN--COST
• CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS
• CONTRACEPTIVE AGENTS--COST
• CONTRACEPTIVE AGENTS--SIDE EFFECTS
• CONTRACEPTIVE METHODS
• CRITIQUE
• DEMOGRAPHIC FACTORS
• DEPO-PROVERA--COST
• DEPO-PROVERA--SIDE EFFECTS
• DISEASES